Notably, it has been well established that TGF-β signaling enhances self-renewal, invasiveness, and the tumorigenic potential of GBM tumors through induction of key stem cell factors such as leukemia inhibitory factor (LIF), inhibitor of DNA-binding proteins (IDs), and SOX family proteins (26–28). The gene discussed is TGFB1; the disease is glioblastoma.